Opera, Italy

Elisabetta Ranucci


 

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 284(Granted Patents)


Location History:

  • Brescia, IT (1997 - 1999)
  • Milan, IT (1997 - 2013)
  • Opera, IT (2013 - 2014)

Company Filing History:


Years Active: 1997-2014

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Elisabetta Ranucci

Introduction

Elisabetta Ranucci is a prominent inventor based in Opera, Italy. She has made significant contributions to the field of antiviral agents and magnetic nanoparticles, holding a total of nine patents. Her work is characterized by a commitment to advancing medical technology and improving treatment options for viral infections.

Latest Patents

Among her latest patents is a formulation of anti-viral agents and compositions that utilize guanidine-based poly (amidoamine) polymers. These polymers are designed for use in the prevention and treatment of viral infections in mammals, particularly humans. Another notable patent involves magnetic nanoparticles that can be applied in hyperthermia, which are described as nanoparticles of magnetic metal oxides that can be incorporated into polymer constructs, potentially including pharmacologically active substances.

Career Highlights

Elisabetta Ranucci has worked with esteemed organizations such as the National Research Council of Italy (Consiglio Nazionale Delle Ricerche) and Asta Medica, Aktiengesellschaft. Her career reflects a dedication to research and innovation in the medical field, contributing to advancements that have the potential to save lives.

Collaborations

Throughout her career, Ranucci has collaborated with notable colleagues, including Paolo Ferruti and Francesco Maria Veronese. These partnerships have fostered a collaborative environment that enhances the development of her innovative ideas.

Conclusion

Elisabetta Ranucci's work exemplifies the impact of innovation in the medical field. Her patents and collaborations highlight her commitment to advancing healthcare solutions. Her contributions continue to influence the landscape of antiviral treatments and medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…